What is the Global market size of the Disinfection Robots Market?

Global Cancer Immunotherapy Market size was valued at USD 39.05 billion in 2021 and is poised to grow from USD 85.6 billion in 2022 to USD 309.67 billion by 2030, growing at a CAGR of 9.6% in the forecast period (2023-2030).

Cancer Immunotherapy Companies

Cancer Immunotherapy Market Competitive Landscape

Cancer Immunotherapy Market Top Player’s Company Profiles

Amgen Inc. (US)
AstraZeneca (UK/Sweden)
Bayer AG (Germany)
Bristol-Myers Squibb (US)
Eli Lilly and Company (US)
Janssen Global Services, LLC (Johnson & Johnson) (US)
Merck & Co., Inc. (US)
Novartis (Switzerland)
Pfizer Inc. (US)
F. Hoffmann-La Roche Ltd (Switzerland)
Gilead Sciences, Inc. (US)
GlaxoSmithKline plc (UK)
AbbVie Inc. (US)
Regeneron Pharmaceuticals, Inc. (US)
Adaptimmune Therapeutics plc (UK)
Incyte Corporation (US)
Bluebird bio, Inc. (US)
BioNTech SE (Germany)
Immunocore Limited (UK)
CureVac N.V. (Germany)
BeiGene, Ltd. (China)
Zymeworks Inc. (Canada)

Cancer Immunotherapy Market

FAQs

Global Cancer Immunotherapy Market size was valued at USD 125.4 billion in 2022 and is poised to grow from USD 135.93 billion in 2023 to USD 259.16 billion by 2031, growing at a CAGR of 8.4% during the forecast period (2024-2031).

Global cancer immunotherapy market is highly competitive with the existence of several large pool players operating around the globe. The major players of the global market are focusing on few business developing strategies including high investment in research & development activities, increasing product innovation, strategic partnerships, and collaborations for the expansion of their geographical presence and strengthen their market position among competitors. 'Amgen Inc. (US) ', 'AstraZeneca (UK/Sweden) ', 'Bayer AG (Germany) ', 'Bristol-Myers Squibb (US) ', 'Eli Lilly and Company (US) ', 'Janssen Global Services, LLC (Johnson & Johnson) (US) ', 'Merck & Co., Inc. (US) ', 'Novartis (Switzerland) ', 'Pfizer Inc. (US) ', 'F. Hoffmann-La Roche Ltd (Switzerland) ', 'Gilead Sciences, Inc. (US) ', 'GlaxoSmithKline plc (UK) ', 'AbbVie Inc. (US) ', 'Regeneron Pharmaceuticals, Inc. (US) ', 'Adaptimmune Therapeutics plc (UK) ', 'Incyte Corporation (US) ', 'Bluebird bio, Inc. (US) ', 'BioNTech SE (Germany) ', 'Immunocore Limited (UK) ', 'CureVac N.V. (Germany) ', 'BeiGene, Ltd. (China) ', 'Zymeworks Inc. (Canada)'

Increase in the adoption of immunotherapy treatment over others like radiation therapy and chemotherapies, having more side-effects is the major factor expected to drive the growth of the global cancer immunotherapy market over the forecast period. The former therapies are completely based on destroying cancer cells by irradiation or surgery, the use of these therapies is often limited because they are estimated to kill several healthy cells ae well. Hence, various end-use industries such as hospitals and surgical centers are moving towards immunotherapy treatment, as it enhances the body’s own immunity with the help of man-made proteins, which is fostering the growth of the global market.Besides, there are several cases where cancer patients are beyond the conventional diagnosis and herein patients avail immunotherapy to counter the spread of cancer. In addition, there are solid examples of positive clinical trial results for advanced or metastatic cancer patients.

Approval of New Drug Class to Surge Market Growth: Immunotherapies in development are expected to offer more treatment options and better outcomes than existing therapies. Newer drug classes, such as monoclonal antibodies and histone deacetylase (HDAC) inhibitors, designed to target receptors associated with multiple myeloma, are poised to shape the market's future.

Globally, North America dominated the cancer immunotherapy market with a healthy market share in 2021 due to the rising incidence of diseases, adoption to high technology devices, and growing geriatric population. Additionally, growing number of biotechnology companies and continuously rising development activities coupled with the high consumer income, are some other factors projected to drive the growth of the market in the region over the coming years.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Cancer Immunotherapy Market Competitive Landscape

Cancer Immunotherapy Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Cancer Immunotherapy Market Competitive Landscape

Cancer Immunotherapy Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Cancer Immunotherapy Market?

Who are the key vendors in the Cancer Immunotherapy Market?

What is the key driver of Cancer Immunotherapy Market?

What is the key market trend for Cancer Immunotherapy Market?

Which region accounted for the largest share in Cancer Immunotherapy Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300